Skip to content

Supplementing Brief Psychotherapy With a Mobile App

Supplementing Brief Psychotherapy With a Mobile App

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05867316
Enrollment
66
Registered
2023-05-19
Start date
2023-09-14
Completion date
2024-06-06
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emotion Regulation, Suicide and Self-harm

Keywords

suicidal ideation, suicide attempts

Brief summary

Suicide is among the leading causes of death worldwide, and the risk of suicide is highest in the period immediately following discharge from inpatient psychiatric care.1Importantly, despite the enormously elevated risk during this period, nearly 50% of patients do not attend scheduled therapy after discharge. Even among those who do attend therapy, however, the skills learned in treatment may be difficult to use during the highly distressing time leading up to and during a suicide crisis. Most traditional treatments are not designed to be effective during a suicide crisis. In order to reduce the risk of suicidal thoughts and behaviors in general and specifically during the post-discharge period, interventions are needed that: (1) are easily adhered to and (2) are accessible and effective during a suicide crisis. As such, the purpose of this research study is to test an innovative, new intervention in order to develop an effective and accessible intervention for those at high risk for suicide

Interventions

BEHAVIORALUnified Protocol

Unified Protocol based treatment, modified for use in brief treatment on inpatient units

Sponsors

Rutgers, The State University of New Jersey
Lead SponsorOTHER
Massachusetts General Hospital
CollaboratorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult status (18+ years) * Admission to eligible units in our partner hospital with a reason for admission having to do with suicide risk * The ability to speak and write English fluently, * Ownership of and consistent access to an internet-capable smartphone (e.g., an iPhone or Android phone)

Exclusion criteria

\- The presence of any factor that impairs an individual's ability to provide informed consent and comprehend and effectively participate in the study including: an inability to speak or write English fluently, the presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, acute intoxication, or the presence of extremely agitated or violent behavior.

Design outcomes

Primary

MeasureTime frameDescription
Momentary Suicidal ThinkingAssessed immediately before and immediately after each in-app skills-practice exercise, across the 28-day (4-week) post-discharge monitoring period; averaged across exercises within participant.This is an 11-point scale regarding momentary self-reported intensity of suicidal urges ("Right now, how strongly do you want to kill yourself?". A score of 0 is equivalent to no suicidal thinking at all ("not at all"), a score of 10 is a score of very extreme suicidal thinking ("Extremely). Lower scores equal less severe suicidal thinking (i.e., a better outcome). Scores are averaged across all participants and all instances of survey completion.
Self-efficacy for Managing Negative EmotionBeginning of study and end-of-study, approximately four weeks post dischargeMeasured using the Patient-Reported Outcomes Measurement Information System (PROMIS) self-efficacy for managing negative emotions scale. The scale is measured with four five-point scale items, summed to a score ranging from 4 to 20 where higher scores are better.

Secondary

MeasureTime frameDescription
Negative EmotionAssessed immediately before and immediately after each in-app skills-practice exercise, across the 28-day (4-week) post-discharge monitoring period; averaged across exercises within participant.Negative emotion ("How negative do you feel right now?") on a 0 to 10 scale, where 0 is not at all negative (i.e., better) and 10 is extremely negative. Slopes were extracted for each participant and then those values were averaged over the whole sample.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATOREvan Kleiman

Rutgers, The State University of New Jersey

Participant flow

Recruitment details

Patients were recruited from an inpatient unit in an open-label study, in which all participants received the same treatment.

Baseline characteristics

Characteristic
Age, Continuous27.8 Years
STANDARD_DEVIATION 11.9
Race/Ethnicity, Customized
Hispanic/Latine
20 Participants
Race/Ethnicity, Customized
Not Hispanic/Latine
39 Participants
Race/Ethnicity, Customized
Unknown
1 Participants
Sex: Female, Male
Female
33 Participants
Sex: Female, Male
Male
27 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 60
other
Total, other adverse events
0 / 60
serious
Total, serious adverse events
0 / 60

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026